China Pharma Holdings Inc., of Haikou City, China, said that it has completed clinical trials for Candesartan, an anti-hypertension drug, and submitted the generic drug production application to China's FDA
GenVec Inc., of Gaithersburg, Md., said 184 deaths have occurred in its ongoing Phase III PACT (Pancreatic Cancer Clinical Trial) study of TNFerade in patients with locally advanced disease, which triggers the next interim analysis of overall survival
Emisphere Technologies Inc., of Cedar Knolls, N.J., reported results from a meta-analysis published in the December 2009 issue of Rheumatology Reports, which concluded that well-designed clinical trials should be conducted to further validate evidence of calcitonin's analgesic action and its potential role in the management of musculoskeletal pain
Arena Pharmaceuticals Inc., of San Diego, reported that positive data from a clinical trial evaluating the abuse potential of lorcaserin were presented in a poster session at the 48th Annual Meeting of the American College of Neuropsychopharmacology
Cel-Sci Corp., of Vienna, Va., started its first clinical study for hospitalized H1N1 patients, which involves taking blood from 20 subjects and activating their cells with the LEAPS-H1N1 investigational therapy in order to assess the cells' response as the basis for the planned future treatment of that patient population under a next-stage clinical trial protocol
The strategy is supported by results from XOMA 052 Phase I trials demonstrating improvement in biomarkers associated with cardiovascular risk, ongoing clinical trials in cardiovascular disease with other IL-1 targeted agents, animal studies with XOMA 052 that have demonstrated significant reductions in plaque formation and improvements in lipid levels, and positive results with another IL-1 targeted agent in an animal model of cardiac remodeling after heart attack, the company said
The clinical trial, titled "CopperProof 2," will test the effects of a gastro-retentive, sustained-release zinc/cysteine combination tablet on the amelioration of subclinical zinc deficiency, and elevated percentage serum-free copper, associated with Alzheimer's disease
pSivida Corp., of Watertown, Mass., said results of a second pancreatic clinical trial showed that 100 percent, or all six patients, experienced stabilization in tumor growth after receiving BrachySil (P32 BioSilicon), a brachytherapy treatment for inoperable pancreatic cancer
GlaxoSmithKline plc, of London, reported results from a second clinical trial of its pandemic (H1N1) adjuvanted vaccine, showing that one dose can provide a strong immune response
There were no serious adverse events in the clinical trial...The last patient will complete the Phase III high grade PIN clinical trial in the first quarter of 2010
Initiation of the clinical trial has triggered an undisclosed milestone payment under the agreement...The study is the second neural stem cell clinical trial for neurodegenerative diseases to be conducted in the U.S. A Phase I trial using the same type of neural stem cells was completed in January, with reported positive safety results and evidence that the cells engrafted into the brain
Affymax Inc., of Palo Alto, Calif., said it notified its clinical trial sites to complete treatment of patients in the Phase III program for the investigational drug, Hematide, by the end of the year...The program involves about 2,600 chronic renal failure patients at more than 400 clinical trial sites
The company anticipates the trial will enroll approximately 500 men, all of whom have had a negative prostate biopsy, at 10 or more clinical trial sites
Seattle Genetics Inc., of Bothell, Wash., completed enrollment of its pivotal clinical trial of brentuximab vedotin (SGN-35) for relapsed and refractory Hodgkin lymphoma
Gen-Probe Inc., of San Diego, started a clinical trial aimed at securing regulatory approval of its Aptima assay for Trichomonas vaginalis on the TIGRIS system
China Pharma Holdings Inc., of Haikou City, China, said that it has completed clinical trials for Candesartan, an anti-hypertension drug, and submitted the generic drug production application to China's FDA